New Study Demonstrates Avenda Health’s Unfold AI to Better Predict Focal Therapy Success by 77% Percent as Compared to Standard Methods
Imaging Technology
MAY 13, 2024
milla1cf Mon, 05/13/2024 - 12:10 May 13, 2024 — Avenda Health , an AI healthcare company creating the future of personalized prostate cancer care , unveils the results of a new UCLA study examining the role of AI in identifying tumor margins and predicting the efficacy of focal therapy treatments. The study titled “Software to Determine Extent of Tumor Margins in Focal Therapy,” was presented at the 2024 American Urological Association’s (AUA) annual meeting by Wayne Brisbane, MD , assistant pr
Let's personalize your content